Vascular endothelial dysfunction has been implicated in the development of cardiovascular diseases and is closely associated with atherosclerosis and hypertension . Vascular dysfunction has been attributed to the impaired ability to vasoconstrictor or dilates . The endothelium releases vasoactive agents such as nitric oxide (NO), prostacyclin (PGI2) and endothelium-derived hyper polarizing factor (EDHF) which are vasodilatory or vasoconstrictive factors such as thromboxane (TXA2) and endothelin-1 (ET-1) . Endothelial mediators like NO and ET1 are known counterparts in the regulation of vasoactive and an imbalance between the two may result in endothelial dysfunction [4, 5]. Enhancement of ET-1 system coupled with lack of NO leads to significant upregulation of blood pressure resulting in hypertension , The role of NO in regulating BP is also well established . Enhanced ET-1 mediated vasoconstriction is also associated with overweight and obesity which contributes to endothelial vasodilator dysfunction . Evidence suggests that NO play a major role in regulating blood pressure and that impaired NO bio activity is an important component of hypertension . HIV-associated cardiovascular diseases have been widely described, but clinical studies aimed at establishing cause-effect relationships between HIV-associated cardiovascular disease and either the HIV infection or antiretroviral therapy has been problematic . However these studies were only performed using the animal model (FVB/n mice), therefore it is of great importance to illustrate its effect (anti-retroviral) on vascular endothelium in humans. Obesity has been identified as a major risk factor for hypertension, increased triglycerides, and elevated serum lipids including hypercholesterolemia . Renal complications are likely long-term effects of hypertension. High levels of waste fat are a leading cause of possible inflammation in blood vessels . Tissue capillaries undergo wall stress in the endothelium in particular thereby leading to impaired oxygen release to cells leading to waste products accumulation . Atherothrombotic problems have been implicated in carotid artery insufficiency, strokes, and circulatory problems . Obesity itself has been clearly shown to disrupt the ET1 mediated vasoconstriction which further leads to endothelial dysfunction resulting in the increased prevalence of hypertension associated with elevated adiposity . The previous study in HIV patients on HAART showed a prevalence of hypertension similar to HIV negative controls although this has been considered as a lesser evil .
The aim of the present study was to evaluate the effects of HIV infection, antiretroviral therapy and its the possible implication in the etiology of hypertension and obesity and its association between endothelin and nitric oxide. The present study attempts to compare endothelin and nitric oxide between HIV groups using univariate and multivariate analysis; to determine the association between gender, blood pressure, body composition and endothelin in each group and to determine the association between endothelin and nitric oxide according to the study groups.
Does HIV treatment or HIV itself contribute to changes in the levels of endothelin and NO in HIV positive patients and HIV positive patients on HAART treatment?
Materials and Methods
This was a descriptive and comparative study.
Ethical and bio-safety clearance was obtained from Walter Sisulu University (protocol number: 023/2012) and the purpose of the study was explained orally and in writing to obtain consent from recruited participants. Participants were informed that they may refuse to participate or withdraw from the study at any time without fear of victimization. Participants were assured of total confidentiality and that there will be no information that identified them in any manner. They were informed that the information will only be utilized for the purposes as stipulated and all possible steps will be taken to ensure that the information remained confidential.
This study was conducted in a random manner, planned to convenience population according to inclusion and exclusion criteria and the expected sample size was 180 participants of different sex groups but 154 participants completed the study.
Place of Research
Participants were recruited from Clinics (Gateway and Infectious disease clinic), Nelson Mandela Academic Hospital (NMAH) in KSD Municipality, in the Eastern Cape Province, South Africa.
HIV patients were considered eligible for inclusion in the study if at the time of data collection they accept to participate in the study by filling in the questionnaire and signing the consent form. The age range of participants was between 20-50 years old, female and males of equal ratio.
Excluded from participation were individuals who were under treatment for hypertension, had used anti-diabetic agents, steroids, growth hormone, oral contraceptives pills, or any anabolic agent, substance abuse, appetite suppressor, pregnant, or had breastfed in the past year, who have or who had an acute infection within 3 months of the study.
154 participants took part in the study and were categorized into the following groups: 57 HIV (+) participants on HAART (Group A), 40 HIV (+) not on HAART participants (Group B), and 57 HIV (-) participants (Group C as controls).
Questionnaires forms (self-designed and tested) were issued to the participants. Body composition indices were measured using anthropometry, bioelectric impedance analysis (BIA) and also by the use of medical equations . The measurements of weight were performed before the use of bioelectric impedance analysis. Height was taken to the nearest 1 cm with the aid of Electronic body scale for weight and height (model: TCS-200-RT, China) with patients wearing light clothes without shoes . Weight (kg), body mass index (BMI in kg/m2), body fat (%), visceral fat levels (%), resting metabolism rate (calorie expenditure of resting body) all were automatically obtained using Omron body composition monitor BF 500 ( Omron, Tokyo, Japan) . Blood pressure was measured using a sphygmomanometer (Automatic blood pressure monitor: Model: KD-525E, Zhe Jiang, China) . JNC-7 Classification and management of blood pressure : Hypotension (< 90 mmHg systolic pressure and <60 mmHg diastolic pressure), normal (90-119 mmHg systolic pressure and 60-79 mmHg diastolic pressure), prehypertension (120-139 mmHg systolic pressure and 80- 89mmHg diastolic pressure), stage 1 hypertension (140- 159 mmHg systolic pressure and 90-99 mmHg diastolic pressure), stage 2 hypertension (160-179 mmHg systolic pressure and 100-119 mmHg diastolic pressure) and hypertensive crisis (≥ 180 mmHg systolic pressure and ≥ 120 mmHg diastolic pressure) . 5 milliliters of venous blood was drawn at 08:00 am before breakfast after 8-12 hrs overnight fast. Fasting blood was collected in tubes containing 50 mmol of EDTA as an anticoagulant. Blood was centrifuged for 15minutes at 1000 x g within 30 minutes to separate serum from the whole blood. Serum samples were stored at -80° C refrigerator in the fridge until the time for analysis. Endothelin assay is an immunometric (i.e. sandwich) EIA that permits endothelin measurement within the range of 0-250 pg/ml . The Griess reagent system will ensure an accurate Nitric Oxide quantization, by preparing a reference curve with the Nitrite Standard for each assay .
Data was analyses using SPSS version 19 for Windows (SPSS, Chicago, U.S.A.). Multiway analysis of variance (MANOVA) and covariance (ANCOVA) was used to explore the association between blood pressure groups, body composition and age, and gender. In addition, these statistics were used to explore the effect of the study variables on the log-transformed hormone levels of ET-1, and NO. Turkey's multiple comparison post-hoc analysis was subsequently used. Descriptive statistics and Comparison study were used to calculate mean ± SD of all variables. Correlation analysis will also be used to look for the degree of correlation between ET-1, NO levels, body composition and arterial blood pressure. A P-value of <0.05 was considered significant.
Among the study population comprising 154 participants, 47 were males and 107 females with a sex ratio of 2 females: 1 male (Figure 1), women were 2/3 (69.48% n=107) and men were 1/3 (30. 52 % n=47). HIV positive patients on HAART (sex ratio almost 2 males: 3 females), HIV positive patients not on HAART (sex ratio 1 male: 3 females) and HIV negative patients (sex ratio almost 1 male: 2 females.
Influence of Gender
Table 1 below represents the characteristics in the study population and the impact of gender on general characteristics in these adults females and males presented similarities in age, waist/hip ratio, systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP) and Endothelin but there was a significance.
when it comes to weight, height, waist circumference (WC), hip circumference (HC), skeletal muscle fat (SMF), whole fat (WF), body mass index (BMI), resting metabolism (RM) and nitric oxide (NO) respectively.
Figure 1: Percentage of Patients in Different Study Groups
Table 1: Mean levels of Variables by Gender in all
Influence of Aging
The largest percentage seemed to be in middle age group and older group (30-39 and >=40) (66%). The lowest percentage is found in young age group (34%). The impact of aging on the general characteristics profile is shown in table 2. There was no significant (P>0.05) influence on height, HC, SMF, WF, RM, SBP, PP, endothelin and NO. However, Waist Circumference (<0.0001), Waist/Hip ratio (<0.005), and Diastolic Blood Pressure (<0.0001) were significantly increased with age.
Table 2: Influence of aging on the mean levels of variables in all
Table 3: Levels of continuous variables in all and by HIV status groups
Table 4: BP and body mass index interactions across the study group
Table 5: Univariately associated factors with presence of arterial hypertension (n=54)
Influence of HIV and HIV on Treatment on Variables
Out of the study population, 57 (37.01%), 40 (25.97%), and 57 (37.01%) participants were HIV positive on treatment, HIV positive not on treatment and HIV negative respectively (Figure 1). Most of the variables presented show no significant difference between the three study groups. However, endothelin and NO levels were significantly different between the study groups(P<0.0001) in table 3. Interaction of blood pressure and Body Mass Index across the HIV status groups are shown in table 4. There was no significant difference in SBP among the different groups. There was a significant difference in DBP and PP between the study groups (p<0.0001). Table 5 shows associated factors attributed to the presence of arterial hypertension in few participants (n=54). There was no significant variation of mean values of nitric oxide or endothelin among hypertensive and non-hypertensive patients. However, there was a significant association in other variables presented. Endothelin levels were higher in non-hypertensive patients who are on HAART treatment. In HIV positive not on treatment, the values of endothelin were significantly higher (P<0.0001) hypertensive's (9.8±1.4 mmHg) than non hypertensive's (6.9±2.5 mmHg), whereas the values of NO did not vary (P=0.403) between hypertensive's (19.9±3.1 units) and non hypertensive's (18.8±4.7 mmHg). In HIV negative patients, the mean endothelin was higher (P<0.0001) in hypertensive's (9.2±1.6 mmHg) than non-hypertensive (6.1±2.3 mmHg), but NO values were similar between hypertensive's (P=0.448) (15±3.2 mmHg) and non-hypertensive (14.4±2.9 mmHg).
This study is a descriptive and comparative study, with a large number of participants (154) gathered into different groups of HIV status, age (18-60 years) and gender (males and females). A large number of the patients were females (69.48%) compared to males (30.52%) (Sex ratio 2 females: 1 male). This supports the fact that in South Africa, a large percentage of attendees in the public or private hospitals are females and are also the most willing to participate in all kinds of research that can facilitate good health.
Gender showed significant impact on different variables which include weight, waist circumference, and hip circumference. These variables are prone to be found high in females all over the world. For total body fat in our study, we included skeletal muscle fat and whole body fat which both have shown to be significantly high in females compared to males. Obesity and its role in the causation of hypertension, elevated triglycerides and hypercholesterolemia are well known . Waist fat is particularly known to be implicated in inflammations in blood vessels.
Body mass index as expected was high in females with its mean value range being 28.4±6.1, which depict overweight and as a sign of early obesity stage. Obesity is one of the earlier markers of renal function disorders , other complications of hypertension in obesity, such as cardiac remodeling and heart failure . Then we continued and looked at the age range in all, our results have shown a significant trend between age and weight, age and waist circumference, age and waist/hip ratio, and also age and diastolic pressure. All these variables increase steadily as age increases from middle age to older age group, so this clearly stipulate high risk of cardiovascular diseases in older participants. However, there was no significant trend to the rest of variables. The results also describe some evidence that males were slightly older than females but not significant.
Impact of HAART and HIV Itself on the Study Variables
There is not much significance presented when comparing HIV positive participant on treatment and HIV positive participant not on treatment to weight but greatly reduced when both are compared to negative participants. This therefore means, HIV itself may have an impact on the weight of HIV positive participants.
HIV positives on treatment and HIV positive not on treatment had levels of BMI, whole fat, SMF, resting metabolism, similar to those of HIV negatives, the levels indicate overweight of the participants. This suggests that all the groups are in risk of pre-exposure to type II diabetes, hypertension, urinary stress, sleep apnea because of elicited BMI. A high BMI is a risk factor for mortality from the overall cardiovascular disease.
The significant value presented by both pressures (SBP and DBP) showed not much correlation. Beneficiary effects of HAART as a whole in reducing the mortality rate in HIV+ patients is to be recognized although the prevalence of hypertension in these patients is to be considered as a minor side effect . In our study, in all groups of participants, a small number (n=54) were presented with arterial hypertension. However, the other variable did not vary significantly across these three groups.
Relationship of Endothelin, Nitric Oxide to HIV Status
The imbalance between the endothelial mediators like ET-1 and NO, which are natural counterparts in vascular functions, is likely to be the causative factors in the progression of vascular disease [ 5]. In our study, both endothelin and nitric oxide showed the significant correlation among HIV groups. In HIV positive patients on treatment, the levels of endothelin were significantly increased. This clearly demonstrates that treatment also has a role in the progression of hypertension. Elevated endothelin may predispose participants to vascular remodeling (change in the vessel structure), vascular hypertrophy, cardiac hypertrophy and endothelial dysfunction. Figure 2: Cellular Signalling Pathway of Endothelin and NO  Figure 2 shows activation of eNOs, due to ET-1 activation
of ET-B receptor and intracellular signaling pathway.
G-protein coupled receptors & TRPC, RTK are also
activators of eNOs. This probably leads to diffusion of NO
to stellate cell, production of GMP and activation of PKG
these results in relaxation of stellate cells which offset the
ETs constrictor effects on stellate cells . On the other hand NO exerts its effects through
activation and allosteric modification of sGC, a hetrodimer NO receptor resulting in enhanced catalytic activity .
The second messenger pathway in this activation seems
to be PKGs . PKG-1 has been reported to be the
predominant in CVS and its possible cellular action in
mediating the anti-proliferative effects of cGMP has been
proposed . PKG exerts its effects through various
means, including IP3 receptor, eventually activating
Calcium and Potassium channels . NO also exerts its
effects through mediation of tyrosine residues . Vasoconstrictor activation via ETA receptor
located on the vascular smooth muscles and simultaneously
activating ETB receptor subtype leads to vasodilatation
by inducing release of NO and PGI2 . ET-1 effects
were found to be different if blood vessels were denuded
or when hemoglobin was present which supposedly has
a scavenging effect on NO. It has also been shown that
vasomotion may be directly related to NO synthesis
. However, this interaction between ET-1 an1 may
induce NO synthesis by the endothelinl NOs as well as
increasing the production of NOs inhibitors, asymmetric
dimethylarginine (ADMA). ADMA has been proven to
potentially decrease the NO bio-availability . Based
on the above mechanisms the ET-1 and NO are shown to
be causative factors in inflammatory diseases like asthma,
arthritis etc . Figure 3: Synthesis of Both ET and NO and Formation of Inflammation  Nitric oxide also stipulated a steady increase
in both HIV positive participants on treatment and HIV
positive participants not on treatment, this demonstrate
that not only changes in BMI can facilitate an increase in
nitric oxide but also HIV itself and HIV status plays huge
The present findings constitute a preliminary
scientific background to understand the path physiology,
the clinical spectrum, and the prevention of HIV/AIDSrelated atherogenesis. The study brought to light an
evidence-based knowledge on the impact of gender, aging,
HIV infection itself, HAART, and BMI changes across the
HIV groups and interaction between endothelin and nitric
The existence and nature of a communication
between HIV infection, HAART and the impact of
relationship between endothelin, nitric oxide pathogenesis
of hypertension warrants further investigations in these
black patients. Future studies may better elucidate the
mechanism of atherogenesis when HIV infected patients
are recovering normal weight. Of particular importance is
the need to elucidate the protective role of endothelin and
nitric oxide against hypertension in HIV positive patients.
Indeed, the present study showed that there is
an uneven relationship between endothelin, nitric oxide
levels and also these two are associated with overweight/
obesity and blood pressure. The findings reveal that the
positive relationship was lost in both HIV positives not on
treatment and HIV positives on HAART, possibly due to
changes in the endothelium, HIV itself and HIV treatment.
Further studies are needed on the relationship between
endothelin, lipid profile, blood pressure and glucose levels
in HIV positive patients.
Endothelin and nitric oxide therapy in case of
deficiency states may assist in the future management
of hypertension on both HIV positive and HIV positives
on HAART. Studies on the effects and safety of status
(lowering-endothelin or lowering-nitric oxide drugs)
should be taken in our hospitals. Health professionals who
are in charge of HIV infected patients have to monitor
BMI, fat redistribution, blood pressure and drug toxicity regularly when these patients visit their clinics/Hospitals.
Appropriate diet (5 different fruits intake/day), physical
activity, and avoidance of known behavioral risk factors
(smoking, excessive alcohol, fat and sugar intake) should
be recommended to HIV infected patients.
The present study might be limited to some degree
by its design (case-control study) to demonstrate a causal
association. The study was limited by age distribution
and over representation of females that made it difficult
to generalize the ability of the results, the strength of this
study comes from strong and significant associations using
statistical analysis as well as from valid and standardized
measurements of anthropometric/body composition, blood
pressure, nitric oxide and endothelin.
The patients who took part in the study from
the Infectious disease Clinic and the Gateway Clinic are
acknowledged with gratitude for their cooperation. The
funding by RAVC to conduct this study is acknowledged.
The WSU research grant is also acknowledged.